“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
Breast Cancer: Targets and Therapy · 2023-07 · Volume 15 · 525-540
DOI: 10.2147/bctt.s340741 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2023-07. Verfasst von Anna Höller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Bich Doan Nguyen-Sträuli, Alexander Ring
Zitieren
APA
Höller, A., Nguyen-Sträuli, B. D., Frauchiger-Heuer, H., & Ring, A. (2023). “Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”. Breast Cancer: Targets and Therapy, Volume 15, 525-540. https://doi.org/10.2147/bctt.s340741
Vancouver
Höller A, Nguyen-Sträuli BD, Frauchiger-Heuer H, Ring A. “Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”. Breast Cancer: Targets and Therapy. 2023;Volume 15:525-540. doi:10.2147/bctt.s340741
BibTeX
@article{Hller2023,
author = {Höller, Anna and Nguyen-Sträuli, Bich Doan and Frauchiger-Heuer, Heike and Ring, Alexander},
title = {“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”},
journal = {Breast Cancer: Targets and Therapy},
year = {2023},
volume = {Volume 15},
pages = {525--540},
doi = {10.2147/bctt.s340741}
}
EUVIMED